300267.SZ · 尔康制药
China A-shares · RS rating 56 · As of 2026-10-14
| Price | 3.17 CNY |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 56 / 66 / 51 / 53 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 10 / 27 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +29.4% |
| Distance from 52-week high | +34.5% |
| Market cap (USD) | $1.0B |